• Jeff Heck, Joel Iverson and Jonathan Baker used to get together for a Friday morning Bible study through Atlanta's Westside Presbyterian Church.

    WSJ: A Lot of Church Folk Are Asking: 'What Would Jesus Brew?'

  • The New York Times, which wrote up the study this morning, talked to one of the researchers, Matthew Dupre, an assistant professor of medicine at Duke.

    FORBES: Losing Your Job Can Put You At Risk Of A Heart Attack

  • The Niswan School for Girls has no electricity or running water, but two hundred girls and women, ranging in age from six to twenty-three, come to study each morning.

    NEWYORKER: After America

  • With a study released this morning, Vertex Pharmaceuticals cemented a key advantage in what is expected to be a booming new market for hepatitis C drugs this morning, increasing its edge over Merck, its main competitor.

    FORBES: Vertex's Big Advantage

  • Children study the national curriculum in the morning and receive a Koranic education in the afternoon.

    ECONOMIST: The state of Islam on Kenya's Swahili coast

  • Many pension consultants fail to disclose conflicts of interest to their clients and accept undisclosed compensation from money managers and brokerages, according to the results of a U.S. Securities and Exchange Commission study, which were released this morning.

    FORBES: Magazine Article

  • Monday morning the New England Journal of Medicine released a study by Steven Nissen, chairman of cardiology at the Cleveland Clinic.

    FORBES: Magazine Article

  • Genentech this morning announced that it has halted enrolling patients in a study testing its Avastin, which is widely forecast to become the best-selling cancer drug ever, in advanced ovarian cancer.

    FORBES: Magazine Article

  • Genentech (nyse: DNA - news - people ) this morning announced that it has halted enrolling patients in a study testing its Avastin, which is widely forecast to become the best-selling cancer drug ever, in advanced ovarian cancer.

    FORBES: Avastin Sales Could Still Hit $7 Billion Per Year

  • Obesity drug developer Vivus posted results from a 2-year study of its combination weight loss pill Qnexa this morning, showing maintenance of an 11.4% and 10.4% weight loss for patients taking two doses of the medicine, compared to 2.5% for patients on placebo.

    FORBES: Vivus Still Facing Rejection -- For Now

  • In Hankins' study, about 260 U.S. women with morning sickness were given either Diclegis or a dummy pill for two weeks.

    NPR: FDA Approves Return Of Drug For Morning Sickness

  • According to a study released by Social TV metrics company Bluefin Labs this morning, men won by a landslide in the tweet-off over Super Tuesday results.

    FORBES: Super Tuesday: Men Win, At Least In Social TV Politics

  • This morning, Pfizer released the top-line data from its study of tofacitinib, the experimental arthritis drug most Wall Street analysts view as its most important experimental drug.

    FORBES: Key Questions Unanswered On Pfizer Drug

  • According to a 1996 study in the American Journal of Cardiology, many people shovel in the early morning, when the risk for heart attacks is higher.

    CNN: Shoveling snow? How to protect your back (and your heart)

  • In a note Thursday morning, Timothy Anderson of Prudential Equity Group said he did not expect a clear answer from the torcetrapib study and that there would need to be "soul searching" for companies developing rival drugs.

    FORBES: A Heart-Pumping Meeting

  • Study researcher Renee Biss, a graduate student at the University of Toronto, said one of the reasons morning people may be happier is because they tend not to suffer from social jet lag.

    CNN: STORY HIGHLIGHTS

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定